Sova Pharmaceuticals

Sova Pharmaceuticals, Inc. is a biopharmaceutical company based in La Jolla, California, focused on the discovery and development of therapeutic drugs for sleep-related breathing disorders and their complications. Founded in 2010, the company addresses various conditions including obesity hypoventilation syndrome, congestive heart failure, central sleep apnea, and obstructive sleep apnea. In addition to its core focus on sleep disorders, Sova Pharmaceuticals also develops innovative therapeutics for inflammatory and neuropathic pain by inhibiting the production of hydrogen sulfide, thereby reducing pain signaling. The company aims to provide effective treatments that improve patient outcomes in these critical areas of health.